Alcon Inc. (NYSE:ACL) recently announced that its shareholders have approved of the company’s merger with Novartis AG (NYSE:NVS). Per the terms of the merger agreement, Alcon shareholders will receive 2.9228 Novartis shares or American Depositary Shares (ADS) along with a cash payment of $8.20 for each share that they hold. We note that the completion [...]